Results 1 to 10 of about 23,559,862 (313)

Concurrent chemo-radiotherapy for locally advanced non-small cell lung cancer using intensity-modulated radiotherapy technique [PDF]

open access: yesAl-Azhar International Medical Journal, 2020
Background: major progress in the management of non-small cell lung cancer emerged in the last years. Survival rate markedly improved in locally advanced non-small cell lung cancer with the use of concurrent chemoradiotherapy treatment.
Ahmed Al-Agamawi   +3 more
doaj   +1 more source

Pneumopericardium as a non-small-cell lung carcinoma complication

open access: yesPolish Journal of Cardio-Thoracic Surgery, 2016
Below we present a case of a young man with symptoms of progressive weakness, fever, cough, rapid decrease in body weight and the presence of a tumor in the left axillary region. The chest radiography and echocardiography revealed gas bubbles in the pericardium.
Kubisa, Anna   +9 more
openaire   +2 more sources

A case of small cell cancer of the breast in a male with synchronous stage IV non-small cell lung carcinoma

open access: yesRare Tumors, 2013
Extrapulmonary small cell carcinomas (EPSCC) are extremely rare. Most reports indicate success with therapy directed at the tumor as if it was pulmonary small cell carcinoma Primary small cell carcinoma of the breast is an uncommon form of EPSCC ...
Laurie Matt   +2 more
doaj   +1 more source

A Case of Advanced Lung Squamous Cell Carcinoma with CLIP1-ALK Fusion Gene

open access: yesChinese Journal of Lung Cancer, 2022
Anaplastic lymphoma kinase (ALK) fusion gene is an important tumor driver gene of non-small cell lung cancer, accounting for about 5% of patients with non-small cell lung cancer, of which 97% are patients with lung adenocarcinoma.
Yue YUAN   +4 more
doaj   +1 more source

CMTM6: a potential biomarker in non-small cell lung carcinoma

open access: yesPolish Journal of Pathology
Lung cancer is the most common cause of cancer-related deaths worldwide. With the advent of immunotherapy, programmed cell death-1 and programmed death ligand 1 (PD-L1) inhibitors have gained clinical importance, driving research into their regulatory ...
Seda Tas Ayçiçek, Sıddıka Fındık
doaj   +1 more source

Influence of ABO blood group on susceptibility to different pathological types of lung cancer: a retrospective study

open access: yesWorld Journal of Surgical Oncology, 2022
Purpose Current research has shown a link between ABO blood group and many diseases. The purpose of this study aimed to investigate the influence of the ABO blood group on the risk of developing different pathological types of lung cancer.
Haotian Yang   +8 more
doaj   +1 more source

Surgically resected sarcomatoid carcinoma of the lung: a nationwide retrospective study in 2010

open access: yesBMC Cancer
Background Sarcomatoid carcinoma of the lung is a rare histological type of non-small cell lung cancer with a poor prognosis. We aimed to investigate the clinicopathological characteristics and prognostic factors of surgically resected sarcomatoid ...
Kaoru Kaseda   +12 more
doaj   +1 more source

The crosstalk between p38 and Akt signaling pathways orchestrates EMT by regulating SATB2 expression in NSCLC cells

open access: yesTumor Biology, 2017
Epithelial–mesenchymal transition is a crucial event for metastasis and could be mediated by several pathways such as phosphoinositide 3-kinase/Akt, mitogen-activated protein kinases, as well as many epigenetic regulators.
Hakan Kucuksayan, Hakan Akca
doaj   +1 more source

Histological transformation of adenocarcinoma to small cell carcinoma lung as a rare mechanism of resistance to epidermal growth factor receptor-tyrosine kinase inhibitors: Report of a case with review of literature

open access: yesLung India, 2018
A subset of non-small cell lung carcinoma (NSCC) harbor active mutations of epidermal growth factor receptor (EGFR). In these, EGFR tyrosine kinase inhibitors (EGFR-TKIs) are recommended as the first-line treatment.
Monalisa Hui   +3 more
doaj   +1 more source

Postoperative radiotherapy for patients with completely resected pathological stage IIIA-N2 non-small cell lung cancer: a preferential benefit for squamous cell carcinoma

open access: yesRadiology and Oncology, 2020
The beneficial effect of postoperative radiotherapy (PORT) on completely resected pathological IIIA-N2 (pIIIA-N2) non-small cell lung cancer (NSCLC) has been a subject of interest with controversy.
Tian Cuimeng   +8 more
doaj   +1 more source

Home - About - Disclaimer - Privacy